TR
Alzex Neuropharma Inc.
TRRI · OTC
$0.00 +0.00% (+$0.00)
Piotroski F-Score Weak
1/9Valuation
-
N/A PEG N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
50 /100
Moderate Beta -4.12x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TRRI
Online
Sector
Basic Materials
Industry
Other Precious Metals
CEO
Robert W. Rosner
Employees
11
Headquarters
Las Vegas